• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[糖尿病患者未来的眼部护理需求、成本及效果]

[Future need of eye care for patients with diabetes mellitus, costs and effectiveness].

作者信息

Crijns H, Casparie A F, Hendrikse F

机构信息

Erasmus Universiteit, Instituut Beleid en Management Gezondheidszorg, Rotterdam.

出版信息

Ned Tijdschr Geneeskd. 1995 Jul 1;139(26):1336-41.

PMID:7617052
Abstract

OBJECTIVE

To determine how much vision loss caused by diabetic retinopathy can be prevented in the Netherlands until 2020, and what resources will be needed to do so.

DESIGN

Computer simulation study.

METHODS

The population forecasts of the Dutch Central Bureau of Statistics constituted the starting points. The literature provided data on the disease progression and the effectiveness of screening and treatment. A new continuous computer simulation assessed one scenario without eye care and four scenarios with different screening frequencies. Effects were measured in sight gain, costs were based on official charges, benefits included savings on disability facilities and reductions in production losses.

RESULTS

The number of diabetic patients was estimated to increase form 287,000 in 1993 to 406,000 in 2020. Compared with a setting without ophthalmic care, full compliance with official screening guidelines would reduce the prevalence of blindness in 2020 by 45% among type I patients, and by 20% among type II patients. Financial benefits would exceed costs for type I, but not for type II diabetes. While the intensity of eye care would rise, the number of eye examinations would increase approximately in the same proportion, but the number of laser treatments would increase at a much slower rate. 30% more ophthalmologists were estimated to be required in 2020.

CONCLUSIONS

The sharp increase in the number of diabetic patients plus the proven effectiveness of photocoagulation will inevitably cause a major rise in the need for ophthalmic care.

摘要

目的

确定到2020年在荷兰可预防多少由糖尿病视网膜病变导致的视力丧失,以及为此需要哪些资源。

设计

计算机模拟研究。

方法

以荷兰中央统计局的人口预测为起点。文献提供了疾病进展以及筛查和治疗效果的数据。一项新的连续计算机模拟评估了一种无眼部护理的情况和四种不同筛查频率的情况。效果以视力改善来衡量,成本基于官方收费,益处包括残疾设施费用的节省和生产损失的减少。

结果

估计糖尿病患者数量将从1993年的28.7万增加到2020年的40.6万。与无眼科护理的情况相比,完全遵守官方筛查指南将使2020年I型患者的失明患病率降低45%,II型患者降低20%。I型糖尿病的经济收益将超过成本,但II型糖尿病则不然。虽然眼部护理的强度会增加,但眼科检查的数量将大致以相同比例增加,而激光治疗的数量增加速度要慢得多。预计到2020年需要多30%的眼科医生。

结论

糖尿病患者数量的急剧增加加上已证实的光凝治疗效果将不可避免地导致眼科护理需求大幅上升。

相似文献

1
[Future need of eye care for patients with diabetes mellitus, costs and effectiveness].[糖尿病患者未来的眼部护理需求、成本及效果]
Ned Tijdschr Geneeskd. 1995 Jul 1;139(26):1336-41.
2
Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy.糖尿病视网膜病变筛查与治疗成本效益的连续计算机模拟分析
Int J Technol Assess Health Care. 1999 Winter;15(1):198-206. doi: 10.1017/s0266462399152899.
3
Cost-effectiveness of detecting and treating diabetic retinopathy.糖尿病视网膜病变检测与治疗的成本效益
Ann Intern Med. 1996 Jan 1;124(1 Pt 2):164-9. doi: 10.7326/0003-4819-124-1_part_2-199601011-00017.
4
Cost-benefit analysis of diabetic eye disease.糖尿病眼病的成本效益分析。
Ophthalmologica. 1996;210(6):348-53. doi: 10.1159/000310742.
5
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.糖尿病患者的预防性眼部护理对联邦政府而言可节省成本。对医疗改革的启示。
Diabetes Care. 1994 Aug;17(8):909-17. doi: 10.2337/diacare.17.8.909.
6
Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology.检测和治疗1型糖尿病患者的视网膜病变。与更好地执行现行指南相关的节约成本情况。美国眼科学会。
Ophthalmology. 1991 Oct;98(10):1565-73; discussion 1574.
7
Early photocoagulation in patients with either type I or type II diabetes.I型或II型糖尿病患者的早期光凝治疗。
Trans Am Ophthalmol Soc. 1996;94:505-37.
8
Cost savings associated with detection and treatment of diabetic eye disease.与糖尿病眼病检测和治疗相关的成本节约。
Pharmacoeconomics. 1995;8 Suppl 1:33-9. doi: 10.2165/00019053-199500081-00008.
9
Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy.糖尿病视网膜病变中血糖控制与眼科护理的成本效益
Health Policy. 2003 Apr;64(1):89-97. doi: 10.1016/s0168-8510(02)00143-4.
10
Cost effectiveness of current approaches to the control of retinopathy in type I diabetics.当前控制I型糖尿病视网膜病变方法的成本效益
Ophthalmology. 1989 Feb;96(2):255-64. doi: 10.1016/s0161-6420(89)32923-x.